Molbio Diagnosti

  • Market Cap: Mid Cap
  • Industry: Healthcare Services
  • ISIN: INE869T01028
  • NSEID: MOLBIO
  • BSEID: 544866
INR
1,246.20
-64.2 (-4.9%)
BSENSE

Sep 24, 03:30 PM

BSE+NSE Vol: 70820

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Net Sales
1,445.69
1,020.42
Other Operating Income
0.00
0.00
Total Operating income
1,445.69
1,020.42
Raw Material Cost
569.92
434.77
Purchase of Finished goods
4.97
2.54
(Increase) / Decrease In Stocks
1.29
-22.47
Employee Cost
145.23
102.79
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
402.83
240.57
Total Expenditure (Excl Depreciation)
1,124.24
758.20
Operating Profit (PBDIT) excl Other Income
321.45
262.22
Other Income
9.48
7.52
Operating Profit (PBDIT)
330.93
269.74
Interest
33.47
17.66
Exceptional Items
-0.49
-11.13
Gross Profit (PBDT)
296.97
240.95
Depreciation
63.64
44.55
Profit Before Tax
233.34
196.40
Tax
67.00
55.85
Provisions and contingencies
0.00
0.00
Profit After Tax
166.34
140.55
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
166.34
140.55
Share in Profit of Associates
-2.20
-1.97
Minority Interest
2.45
6.52
Other related items
0.00
0.00
Consolidated Net Profit
166.59
145.10
Equity Capital
11.28
2.26
Face Value
1.0
1.0
Reserves
1,158.06
966.14
Earnings per share (EPS)
14.77
64.2
Diluted Earnings per share
14.77
64.06
Operating Profit Margin (Excl OI)
22.24%
25.7%
Gross Profit Margin
20.54%
23.61%
PAT Margin
11.35%
13.58%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 35.23% vs 28.42% in Mar 2025

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2026 is 3.44% vs 25.84% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 11.63% vs 10.77% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 161.29% vs 16.43% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has fallen from Mar 2025

Compare Annual Results Of Molbio Diagnosti With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,445.69
3,738.70
-2,293.01
-61.33%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,445.69
3,738.70
-2,293.01
-61.33%
Raw Material Cost
569.92
911.20
-341.28
-37.45%
Purchase of Finished goods
4.97
0.00
4.97
(Increase) / Decrease In Stocks
1.29
7.40
-6.11
-82.57%
Employee Cost
145.23
1,104.90
-959.67
-86.86%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
402.83
796.70
-393.87
-49.44%
Total Expenditure (Excl Depreciation)
1,124.24
2,820.20
-1,695.96
-60.14%
Operating Profit (PBDIT) excl Other Income
321.45
918.50
-597.05
-65.00%
Other Income
9.48
70.70
-61.22
-86.59%
Operating Profit (PBDIT)
330.93
989.20
-658.27
-66.55%
Interest
33.47
48.80
-15.33
-31.41%
Exceptional Items
-0.49
-76.60
76.11
99.36%
Gross Profit (PBDT)
296.97
863.80
-566.83
-65.62%
Depreciation
63.64
452.90
-389.26
-85.95%
Profit Before Tax
233.34
410.90
-177.56
-43.21%
Tax
67.00
94.20
-27.20
-28.87%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
166.34
316.70
-150.36
-47.48%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
166.34
316.70
-150.36
-47.48%
Share in Profit of Associates
-2.20
0.00
-2.20
Minority Interest
2.45
0.00
2.45
Other related items
0.00
0.00
0.00
Consolidated Net Profit
166.59
316.70
-150.11
-47.40%
Equity Capital
11.28
402.90
-391.62
-97.20%
Face Value
1.00
10.00
0.00
Reserves
1,158.06
4,436.20
-3,278.14
-73.90%
Earnings per share (EPS)
14.77
7.86
6.91
87.91%
Diluted Earnings per share
14.77
7.87
6.90
87.67%
Operating Profit Margin (Excl OI)
22.24%
24.57%
0.00
-2.33%
Gross Profit Margin
20.54%
23.10%
0.00
-2.56%
PAT Margin
11.35%
8.47%
0.00
2.88%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 1,313.40 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 35.23% vs 28.42% in Mar 2025

Annual - Standalone Net Profit
Standalone Net Profit 144.63 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 3.44% vs 25.84% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 251.86 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 11.63% vs 10.77% in Mar 2025

Annual - Interest
Interest 23.15 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 161.29% vs 16.43% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.18%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has fallen from Mar 2025

Footer loading